Literature DB >> 23980113

Short-lived effector CD8 T cells induced by genetically attenuated malaria parasite vaccination express CD11c.

Laura A Cooney1, Megha Gupta, Sunil Thomas, Sebastian Mikolajczak, Kimberly Y Choi, Claire Gibson, Ihn K Jang, Sam Danziger, John Aitchison, Malcolm J Gardner, Stefan H I Kappe, Ruobing Wang.   

Abstract

Vaccination with a single dose of genetically attenuated malaria parasites can induce sterile protection against sporozoite challenge in the rodent Plasmodium yoelii model. Protection is dependent on CD8(+) T cells, involves perforin and gamma interferon (IFN-γ), and is correlated with the expansion of effector memory CD8(+) T cells in the liver. Here, we have further characterized vaccine-induced changes in the CD8(+) T cell phenotype and demonstrated significant upregulation of CD11c on CD3(+) CD8b(+) T cells in the liver, spleen, and peripheral blood. CD11c(+) CD8(+) T cells are predominantly CD11a(hi) CD44(hi) CD62L(-), indicative of antigen-experienced effector cells. Following in vitro restimulation with malaria-infected hepatocytes, CD11c(+) CD8(+) T cells expressed inflammatory cytokines and cytotoxicity markers, including IFN-γ, tumor necrosis factor alpha (TNF-α), interleukin-2 (IL-2), perforin, and CD107a. CD11c(-) CD8(+) T cells, on the other hand, expressed negligible amounts of all inflammatory cytokines and cytotoxicity markers tested, indicating that CD11c marks multifunctional effector CD8(+) T cells. Coculture of CD11c(+), but not CD11c(-), CD8(+) T cells with sporozoite-infected primary hepatocytes significantly inhibited liver-stage parasite development. Tetramer staining for the immunodominant circumsporozoite protein (CSP)-specific CD8(+) T cell epitope demonstrated that approximately two-thirds of CSP-specific cells expressed CD11c at the peak of the CD11c(+) CD8(+) T cell response, but CD11c expression was lost as the CD8(+) T cells entered the memory phase. Further analyses showed that CD11c(+) CD8(+) T cells are primarily KLRG1(+) CD127(-) terminal effectors, whereas all KLRG1(-) CD127(+) memory precursor effector cells are CD11c(-) CD8(+) T cells. Together, these results suggest that CD11c marks a subset of highly inflammatory, short-lived, antigen-specific effector cells, which may play an important role in eliminating infected hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23980113      PMCID: PMC3811835          DOI: 10.1128/IAI.00871-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  T cells as mediators of protective immunity against liver stages of Plasmodium.

Authors:  Moriya Tsuji; Fidel Zavala
Journal:  Trends Parasitol       Date:  2003-02

2.  Hepatocyte perfusion, isolation, and culture.

Authors:  John B Sacci
Journal:  Methods Mol Med       Date:  2002

Review 3.  CD8 T cell responses to infectious pathogens.

Authors:  Phillip Wong; Eric G Pamer
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

4.  CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.

Authors:  W R Weiss; M Sedegah; R L Beaudoin; L H Miller; M F Good
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  Mac-1: a macrophage differentiation antigen identified by monoclonal antibody.

Authors:  T Springer; G Galfré; D S Secher; C Milstein
Journal:  Eur J Immunol       Date:  1979-04       Impact factor: 5.532

6.  Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.

Authors:  R S Nussenzweig; J Vanderberg; H Most; C Orton
Journal:  Nature       Date:  1967-10-14       Impact factor: 49.962

7.  Memory phenotype CD8(+) T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites.

Authors:  M Guebre-Xabier; R Schwenk; U Krzych
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

8.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

Authors:  Stephen L Hoffman; Lucy M L Goh; Thomas C Luke; Imogene Schneider; Thong P Le; Denise L Doolan; John Sacci; Patricia de la Vega; Megan Dowler; Chris Paul; Daniel M Gordon; Jose A Stoute; L W Preston Church; Martha Sedegah; D Gray Heppner; W Ripley Ballou; Thomas L Richie
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

9.  Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites.

Authors:  Noah S Butler; Nathan W Schmidt; John T Harty
Journal:  J Immunol       Date:  2010-01-22       Impact factor: 5.422

Review 10.  Assay of caspase activation in situ combined with probing plasma membrane integrity to detect three distinct stages of apoptosis.

Authors:  Piotr Smolewski; Jerzy Grabarek; H Dorota Halicka; Zbigniew Darzynkiewicz
Journal:  J Immunol Methods       Date:  2002-07-01       Impact factor: 2.303

View more
  18 in total

1.  CD40 is required for protective immunity against liver stage Plasmodium infection.

Authors:  Sara A Murray; Isaac Mohar; Jessica L Miller; Katherine J Brempelis; Ashley M Vaughan; Stefan H I Kappe; Ian N Crispe
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

2.  Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.

Authors:  Xiaohong Peng; Gladys J Keitany; Marissa Vignali; Lin Chen; Claire Gibson; Kimberly Choi; Fusheng Huang; Ruobing Wang
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

3.  Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria.

Authors:  Gladys J Keitany; Brandon Sack; Hannah Smithers; Lin Chen; Ihn K Jang; Leslie Sebastian; Megha Gupta; D Noah Sather; Marissa Vignali; Ashley M Vaughan; Stefan H I Kappe; Ruobing Wang
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

4.  Opening a niche for therapy: local lymphodepletion helps the immune system to fight melanoma.

Authors:  Karsten Mahnke; Alexander Skorokhod; Stefan Grabbe; Alexander H Enk
Journal:  J Invest Dermatol       Date:  2014-07       Impact factor: 8.551

5.  Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem.

Authors:  David L Sacks
Journal:  Nat Immunol       Date:  2014-05       Impact factor: 25.606

6.  High expression of CD11c indicates favorable prognosis in patients with gastric cancer.

Authors:  Yuan Wang; Bin Xu; Wen-Wei Hu; Lu-Jun Chen; Chang-Ping Wu; Bin-Feng Lu; Yue-Ping Shen; Jing-Ting Jiang
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

7.  CD11c-Positive Dendritic Cells in Triple-negative Breast Cancer.

Authors:  Heejae Lee; Hee Jin Lee; In Hye Song; Won Seon Bang; Sun-Hee Heo; Gyungyub Gong; In Ah Park
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

8.  Distinct CD4 T-cell effects on primary versus recall CD8 T-cell responses during viral encephalomyelitis.

Authors:  Mihyun Hwang; Timothy W Phares; David R Hinton; Stephen A Stohlman; Cornelia C Bergmann; Booki Min
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

9.  Identification of pre-erythrocytic malaria antigens that target hepatocytes for killing in vivo and contribute to protection elicited by whole-parasite vaccination.

Authors:  Lin Chen; Gladys J Keitany; Xiaohong Peng; Claire Gibson; Isaac Mohar; Marissa Vignali; Ian N Crispe; Fusheng Huang; Ruobing Wang
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

Review 10.  Tissue signatures influence the activation of intrahepatic CD8(+) T cells against malaria sporozoites.

Authors:  Alexandre Morrot; Maurício M Rodrigues
Journal:  Front Microbiol       Date:  2014-08-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.